Evidence mapPaperPMID 38874882Full record

Trial reportEuropean journal of sport science2024

The effect of 12 weeks of aerobic exercise training with or without saffron supplementation on diabetes-specific markers and inflammation in women with type 2 diabetes: A randomized double-blind placebo-controlled trial.

Ali Rajabi, Ali Akbar Nezhad Gharehlo, Elham Madadizadeh, Aref Basereh, Kimya Khoramipoor, Hossein Pirani, Karen Khoramipour, Othmar Moser, Kayvan Khoramipour

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in European journal of sport science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Adverse Events of Saffron (Health science reports · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ali RajabiFaculty of Educational Sciences and Psychology, Department of Exercise Physiology, University of Mohaghegh Ardabili, Ardabil, Iran.
Ali Akbar Nezhad GharehloFaculty of Physical Education and Sport Sciences, Department of Exercise Physiology, University of Tehran, Tehran, Iran.
Elham MadadizadehFaculty of Physical Education, Department of Exercise Physiology, Shahid Bahonar University, Kerman, Iran.ORCID https://orcid.org/0009-0002-4230-6510
Aref BaserehDepartment Exercise Physiology, Kharazmi University, Tehran, Iran.
Kimya KhoramipoorFaculty of Nursing and Midwifery, Department of Nursing, Kurdistan University of Medical Sciences, Kurdistan, Iran.
Hossein PiraniFaculty of Marine Sciences, Department of Science, Maritim University of Chabahar, Chabahar, Iran.
Karen KhoramipourFaculty of Humanities and Social Sciences, Department of Sport Science, Kurdistan University, Kurdistan, Iran.
Othmar MoserExercise Physiology and Metabolism (Sports Medicine), BaySpo-Bayreuth Centre of Sports Science, University of Bayreuth, Bayreuth, Germany.
Kayvan KhoramipourNeuroscience Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study was conducted to investigate the effects of 12 weeks of aerobic exercise (AT) and saffron supplementation on hemostasis, inflammatory markers, and insulin resistance in obese women diagnosed with type 2 diabetes (T2D). A total of 44 women with T2D (mean age: 54.12 ± 5.63 years, mean BMI: 31.15 ± 1.50 kg/m

Indexed as

BiomarkersCrocusDiabetes Mellitus, Type 2Dietary SupplementsExerciseInsulin ResistanceBlood GlucoseDouble-Blind MethodFemaleHemostasisHumansInflammationInterleukin-6Middle AgedObesityTumor Necrosis Factor-alphaBiomarkersBlood GlucoseInterleukin-6Tumor Necrosis Factor-alphaaerobic trainingFIBHCYIL‐6obesitysaffronTNF‐αtype 2 diabetes

Identifiers

PMID38874882
PMCPMC11235750

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.